Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

Neuroactive steroids affect cocaine's rewarding effects through the sigma1 receptor.

5-Alpha-Reductase Inhibitors can cause negative side effects.

Four-amino acid part makes enzyme sensitive to finasteride.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

A new compound effectively inhibits human 5α-reductase 1.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

New compounds may help treat prostate issues without affecting androgen receptors.

5α-Reductase inhibitors can negatively impact sexual function.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Trazodone might help reverse post finasteride syndrome.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in Tourette syndrome patients.

Finasteride reduces opioid use and withdrawal symptoms in animals.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

5α-reductase inhibitors help treat prostate enlargement and hair loss but may cause side effects, requiring careful use.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

5α-reductase inhibitors like finasteride and dutasteride can help treat skin disorders stimulated by androgens, such as hair loss and acne.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.